The opportunity to decrease the number of doctor-office, infusion-center or hospital visits is welcome news - both for people with serious anemia and their families who have to deal with driving and waiting hours while their loved ones are getting treatments.

We have some way to go, though, before this drug will be approved for use in people with stroke. We need to learn the extent of its benefits, optimal initiation of treatment time and duration of treatment, as well as long-term side effects associated with treatment.

When you talk about cutting prescription costs, many people think automatically about buying drugs from Canada or Mexico.

This is an exciting new development. Even small improvements in decreasing disabilities in stroke survivors mean a lot to patients themselves and their families.

Unfortunately, the spectrum of treatment options for depression in pregnant women is narrow, and other medicines, such as benzodiazepines, carry a Category D pregnancy risk factor with a significant confirmed risk to human fetuses.

For example, the prevalence of migraines is similar in boys and girls before puberty, but later the prevalence is about three times higher in women than men.